Stock SBM SIRONA BIOCHEM CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Company Sirona Biochem Corp.

Equities

SBM

CA82967M1005

Biotechnology & Medical Research

Market Closed - Toronto S.E.
Other stock markets
 10:39:13 26/04/2024 pm IST 		5-day change 1st Jan Change
0.065 CAD -7.14% Intraday chart for Sirona Biochem Corp. +8.33% -45.83%
08/04 Sirona Biochem Provides Update on Anti-Aging Product MT
04/04 Sirona Biochem Corp. announced that it has received CAD 0.1325 million in funding CI

Business Summary

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

Sales per Business

CAD in Million2022Weight2023Weight Delta
Cosmetic and Pharmaceutical Active Ingredients
100.0 %
1 100.0 % 0 100.0 % -94.82%

Managers

Managers TitleAgeSince
Howard Verrico CEO
 Chief Executive Officer - 19/06/19
Christopher Hopton DFI
 Director of Finance/CFO - 29/09/29
Géraldine Deliencourt-Godefroy CTO
 Chief Tech/Sci/R&D Officer - 31/11/31

Members of the board

Members of the board TitleAgeSince
Howard Verrico CEO
 Chief Executive Officer - 19/06/19
Alex Marazzi BRD
 Director/Board Member - 19/06/19
Christopher Hopton DFI
 Director of Finance/CFO - 29/09/29
Géraldine Deliencourt-Godefroy CTO
 Chief Tech/Sci/R&D Officer - 31/11/31
Jason Tian BRD
 Director/Board Member - 07/19/07

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 255,129,505 227,964,516 ( 89.35 %) 0 89.35 %

Shareholders

NameEquities%Valuation
Géraldine Deliencourt-Godefroy
4.238 %
10,400,000 4.238 % 499 200 $
Howard Verrico
4.016 %
9,855,695 4.016 % 473 073 $
Jason Tian
1.231 %
3,020,000 1.231 % 144 960 $
Alex Marazzi
1.084 %
2,660,769 1.084 % 127 717 $
Chris Verrico
0.6416 %
1,574,539 0.6416 % 75 578 $
Christopher Hopton
0.5006 %
1,228,525 0.5006 % 58 969 $

Company contact information

Sirona Biochem Corp.

595 Burrard Street Suite 1600

V7X 1L4, Vancouver

+604-641-4466

http://www.sironabiochem.com
address Sirona Biochem Corp.(SBM)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per region

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
SIRONA BIOCHEM CORP. Stock Sirona Biochem Corp.
-45.83% 12.18M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. SBM Stock
  4. Company Sirona Biochem Corp.